These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36483536)

  • 1. Phosphoproteomic mapping of CCR5 and ACKR2 signaling properties.
    Vacchini A; Maffioli E; Di Silvestre D; Cancellieri C; Milanesi S; Nonnis S; Badanai S; Mauri P; Negri A; Locati M; Tedeschi G; Borroni EM
    Front Mol Biosci; 2022; 9():1060555. PubMed ID: 36483536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical chemokine receptor ACKR2 mediates chemokine scavenging by primary human trophoblasts and can regulate fetal growth, placental structure, and neonatal mortality in mice.
    Teoh PJ; Menzies FM; Hansell CA; Clarke M; Waddell C; Burton GJ; Nelson SM; Nibbs RJ
    J Immunol; 2014 Nov; 193(10):5218-28. PubMed ID: 25297873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of Cytoskeletal Dynamics by β-Arrestin1/Myosin Vb Signaling Regulates Endosomal Sorting and Scavenging Activity of the Atypical Chemokine Receptor ACKR2.
    Vacchini A; Cancellieri C; Milanesi S; Badanai S; Savino B; Bifari F; Locati M; Bonecchi R; Borroni EM
    Vaccines (Basel); 2020 Sep; 8(3):. PubMed ID: 32957704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The atypical chemokine receptor ACKR2 drives pulmonary fibrosis by tuning influx of CCR2
    Russo RC; Savino B; Mirolo M; Buracchi C; Germano G; Anselmo A; Zammataro L; Pasqualini F; Mantovani A; Locati M; Teixeira MM
    Am J Physiol Lung Cell Mol Physiol; 2018 Jun; 314(6):L1010-L1025. PubMed ID: 29469612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACKR2 contributes to pulmonary dysfunction by shaping CCL5:CCR5-dependent recruitment of lymphocytes during influenza A infection in mice.
    Tavares LP; Garcia CC; Gonçalves APF; Kraemer LR; Melo EM; Oliveira FMS; Freitas CS; Lopes GAO; Reis DC; Cassali GD; Machado AM; Mantovani A; Locati M; Teixeira MM; Russo RC
    Am J Physiol Lung Cell Mol Physiol; 2020 Apr; 318(4):L655-L670. PubMed ID: 31995405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL10 Is an Agonist of the CC Family Chemokine Scavenger Receptor ACKR2/D6.
    Chevigné A; Janji B; Meyrath M; Reynders N; D'Uonnolo G; Uchański T; Xiao M; Berchem G; Ollert M; Kwon YJ; Noman MZ; Szpakowska M
    Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33801414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of conventional and atypical receptors for the chemokine CCL2 on mouse leukocytes.
    Ford LB; Cerovic V; Milling SW; Graham GJ; Hansell CA; Nibbs RJ
    J Immunol; 2014 Jul; 193(1):400-11. PubMed ID: 24890717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-146 and cell trauma down-regulate expression of the psoriasis-associated atypical chemokine receptor ACKR2.
    Shams K; Kurowska-Stolarska M; Schütte F; Burden AD; McKimmie CS; Graham GJ
    J Biol Chem; 2018 Feb; 293(8):3003-3012. PubMed ID: 29279330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The N-terminal region of the atypical chemokine receptor ACKR2 is a key determinant of ligand binding.
    Hewit KD; Fraser A; Nibbs RJ; Graham GJ
    J Biol Chem; 2014 May; 289(18):12330-42. PubMed ID: 24644289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Atypical Chemokine Receptor D6 (ACKR2) in Physiological and Pathological Conditions; Friend, Foe, or Both?
    Gowhari Shabgah A; Jadidi-Niaragh F; Mohammadi H; Ebrahimzadeh F; Oveisee M; Jahanara A; Gholizadeh Navashenaq J
    Front Immunol; 2022; 13():861931. PubMed ID: 35677043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and expression analysis of an atypical chemokine receptor-2 (ACKR2)/CC chemokine binding protein-2 (CCBP2) in rainbow trout (Oncorhynchus mykiss).
    Qi Z; Jiang Y; Holland JW; Nie P; Secombes CJ; Wang T
    Fish Shellfish Immunol; 2015 Jun; 44(2):389-98. PubMed ID: 25747793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical chemokine receptor ACKR2-V41A has decreased CCL2 binding, scavenging, and activation, supporting sustained inflammation and increased Alzheimer's disease risk.
    Murcia JDG; Weinert A; Freitas CMT; Arens DK; Ferrel MN; Grose JH; Ridge PG; Wilson E; Kauwe JSK; Weber KS
    Sci Rep; 2020 May; 10(1):8019. PubMed ID: 32415244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The atypical chemokine receptor 2 limits renal inflammation and fibrosis in murine progressive immune complex glomerulonephritis.
    Bideak A; Blaut A; Hoppe JM; Müller MB; Federico G; Eltrich N; Gröne HJ; Locati M; Vielhauer V
    Kidney Int; 2018 Apr; 93(4):826-841. PubMed ID: 29395335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The scavenging chemokine receptor ACKR2 has a significant impact on acute mortality rate and early lesion development after traumatic brain injury.
    Woodcock TM; Frugier T; Nguyen TT; Semple BD; Bye N; Massara M; Savino B; Besio R; Sobacchi C; Locati M; Morganti-Kossmann MC
    PLoS One; 2017; 12(11):e0188305. PubMed ID: 29176798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACKR2: An Atypical Chemokine Receptor Regulating Lymphatic Biology.
    Bonavita O; Mollica Poeta V; Setten E; Massara M; Bonecchi R
    Front Immunol; 2016; 7():691. PubMed ID: 28123388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated ACKR2 expression is a common feature of inflammatory arthropathies.
    Baldwin HM; Singh MD; Codullo V; King V; Wilson H; McInnes I; Graham GJ
    Rheumatology (Oxford); 2017 Sep; 56(9):1607-1617. PubMed ID: 28486662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal Protection by Genetic Deletion of the Atypical Chemokine Receptor ACKR2 in Diabetic OVE Mice.
    Zheng S; Coventry S; Cai L; Powell DW; Jala VR; Haribabu B; Epstein PN
    J Diabetes Res; 2016; 2016():5362506. PubMed ID: 26798651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of atypical chemokine receptor ACKR2 in experimental oral squamous cell carcinogenesis.
    da Silva JM; Dos Santos TPM; Saraiva AM; Fernandes de Oliveira AL; Garlet GP; Batista AC; de Mesquita RA; Russo RC; da Silva TA
    Cytokine; 2019 Jun; 118():160-167. PubMed ID: 29550065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoluciferase-based methods to monitor activation, modulation and trafficking of atypical chemokine receptors.
    Luís R; D'Uonnolo G; Palmer CB; Meyrath M; Uchański T; Wantz M; Rogister B; Janji B; Chevigné A; Szpakowska M
    Methods Cell Biol; 2022; 169():279-294. PubMed ID: 35623707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of atypical chemokine receptor 2/ackr2 in bone remodeling.
    Lima ILA; Silva JMD; Rodrigues LFD; Madureira DF; Fonseca AC; Garlet GP; Teixeira MM; Russo RC; Fukada SY; Silva TAD
    Bone; 2017 Aug; 101():113-122. PubMed ID: 28476575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.